Diabetic Retinopathy Predicts Risk of Alzheimer's Disease: A Danish Registry-Based Nationwide Cohort Study
Version 3 2024-06-19, 12:28Version 3 2024-06-19, 12:28
Version 2 2024-06-06, 12:28Version 2 2024-06-06, 12:28
Version 1 2023-02-28, 00:20Version 1 2023-02-28, 00:20
journal contribution
posted on 2024-06-19, 12:28authored byFN Pedersen, L Stokholm, F Pouwer, K Hass Rubin, T Peto, U Frydkjær-Olsen, AS Thykjær, N Andersen, J Andresen, T Bek, M La Cour, S Heegaard, K Højlund, R Kawasaki, JN Hajari, K Ohm Kyvik, CS Laugesen, KC Schielke, R Simó, J Grauslund
Background: Retinal neurodegeneration is evident in early diabetic retinopathy (DR) which may be associated with other neurodegenerative diseases like Alzheimer's disease (AD). Objective: To investigate diabetes and DR as a risk marker of present and incident AD. Methods: A register-based cohort study was performed. We included 134,327 persons with diabetes above 60 years of age, who had attended DR screening, and 651,936 age- and gender-matched persons without diabetes. Results: At baseline, the prevalence of AD was 0.7% and 1.3% among patients with and without diabetes, respectively. In a multivariable regression model, patients with diabetes were less likely to have AD at baseline (adjusted OR 0.63, 95% CI 0.59–0.68). During follow-up, incident AD was registered for 1473 (0.35%) and 6,899 (0.34%) persons with and without diabetes, respectively. Compared to persons without diabetes, persons with diabetes and no DR had a lower risk to develop AD (adjusted HR 0.87, 95% CI 0.81–0.93), while persons with diabetes and DR had higher risk of AD (adjusted HR 1.24, 95% CI 1.08–1.43). When persons with diabetes and no DR were used as references, a higher risk of incident AD was observed in persons with DR (adjusted HR 1.34, 95% CI 1.18–1.53). Conclusion: Individuals with diabetes without DR were less likely to develop AD compared to persons without diabetes. However, individuals with DR had a 34% higher risk of incident AD, which raise the question whether screening for cognitive impairment should be done among individuals with DR.